Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 10/2009

01-10-2009 | Original Paper

The antiangiogenic effects of tyroservatide on animal models of hepatocellular carcinoma

Authors: Ning Zhang, Lu Wang, Ying Liang, Yi-Ming Zhao, Qiong Xue, Wei-Zhong Wu, Hui-Chuan Sun, Jia Fan, Zhao-You Tang

Published in: Journal of Cancer Research and Clinical Oncology | Issue 10/2009

Login to get access

Abstract

Purpose

To investigate the tumor inhibition and antiangiogenic effects of Tyroservatide (YSV, a small polypeptide composed of 3 amino acids. The chemical structure of YSV is l-tyrosine–l-serine–l-valine, molecular structure is C17H25N3O6, and molecular weight is 367.40 Da) on human hepatocarcinoma SMMC-7721 transplanted tumors in nude mice.

Methods

The nude mice bearing xenografts of human hepatocarcinoma SMMC-7721 tumors were daily given intraperitoneal injection of YSV or saline as a control group after the tumor was implanted, total four groups with six mice in each. Calculating tumor volume and measuring tumor weight determined the extent of inhibition of xenografts. The microvessel density (MVD) of tumor tissue was measured by immunohistochemistry. Angiogenesis-related gene expression profile in tumor tissue was assayed by Oligo gene chip and checked by real-time PCR. The Serum concentration of selected factors was measured by ELISA.

Result

YSV at 160, 320, or 640 μg/kg/day inhibited tumor growth in nude mice by 42.62, 60.66, and 27.59%, respectively, which were lower than that of control (P < 0.05). Immunohistochemical staining of the tumor tissue showed the decrease in MVD of tumor tissue after YSV injection. Comparing the 113 genes related with angiogenesis, we found that 18 genes showed the significant difference between the YSV groups and the control; vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8) were the leading ones. The mRNA level as well as ELISA of VEGF and IL-8 in YSV group (320 μg/kg/day) were significantly decreased compared with the control (P < 0.05).

Conclusion

YSV could inhibit the growth of human hepatocarcinoma SMMC-7721 tumor in nude mice, which might attribute to the inhibition of expression of angiogenesis-related factors in mRNA and protein level.
Literature
go back to reference Adler KB, Fischer BM, Wright DT, Cohn LA, Becker S (1994) Interactions between respiratory epithelial cells and cytokines: relationships to lung inflammation. Ann N Y Acad Sci 725:128–145PubMed Adler KB, Fischer BM, Wright DT, Cohn LA, Becker S (1994) Interactions between respiratory epithelial cells and cytokines: relationships to lung inflammation. Ann N Y Acad Sci 725:128–145PubMed
go back to reference Akiba J, Yano H, Ogasawara S, Higaki K, Kojiro M (2001) Expression and function of interleukin-8 in human hepatocellular carcinoma. Int J Oncol 18:257–264PubMed Akiba J, Yano H, Ogasawara S, Higaki K, Kojiro M (2001) Expression and function of interleukin-8 in human hepatocellular carcinoma. Int J Oncol 18:257–264PubMed
go back to reference Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodés J, EASL Panel of Experts on HCC (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430. doi:10.1016/S0168-8278(01)00130-1 CrossRefPubMed Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodés J, EASL Panel of Experts on HCC (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430. doi:10.​1016/​S0168-8278(01)00130-1 CrossRefPubMed
go back to reference Desbaillets I, Diserens AC, Tribolet N, Hamou MF, Van Meir EG (1997) Up-regulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis. J Exp Med 186:1201–1212. doi:10.1084/jem.186.8.1201 CrossRefPubMed Desbaillets I, Diserens AC, Tribolet N, Hamou MF, Van Meir EG (1997) Up-regulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis. J Exp Med 186:1201–1212. doi:10.​1084/​jem.​186.​8.​1201 CrossRefPubMed
go back to reference Fujisawa N, Sakao Y, Hayashi S, Hadden WA 3rd, Harmon CL, Miller EJ (2000) Alpha-chemokine growth factor for adenocarcinomas, a synthetic peptide inhibitor for alpha-chemokines inhibits the growth of adenocarcinoma cell lines. J Cancer Res Clin Oncol 126:19–26. doi:10.1007/PL00008460 CrossRefPubMed Fujisawa N, Sakao Y, Hayashi S, Hadden WA 3rd, Harmon CL, Miller EJ (2000) Alpha-chemokine growth factor for adenocarcinomas, a synthetic peptide inhibitor for alpha-chemokines inhibits the growth of adenocarcinoma cell lines. J Cancer Res Clin Oncol 126:19–26. doi:10.​1007/​PL00008460 CrossRefPubMed
go back to reference Huang S, Mills L, Mian B, Tellez C, McCarty M, Yang XD, Gudas JM, Bar-Eli M (2002) Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. Am J Pathol 161:125–134PubMed Huang S, Mills L, Mian B, Tellez C, McCarty M, Yang XD, Gudas JM, Bar-Eli M (2002) Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. Am J Pathol 161:125–134PubMed
go back to reference Jia J, Lu R, Zhou CL, Zhao L, Fu Z, Zhu ZT, Wang L, Zheng MN, Yang J, Zhang YJ, Yao Z (2006) Gene-chip analysis of the effect of tripeptide tyroservatide (YSV) on gene-expression in human hepatocarcinoma BEL-7402 tumors transplanted to nude mice. Mol Carcinog 45:197–203. doi:10.1002/mc.20172 CrossRefPubMed Jia J, Lu R, Zhou CL, Zhao L, Fu Z, Zhu ZT, Wang L, Zheng MN, Yang J, Zhang YJ, Yao Z (2006) Gene-chip analysis of the effect of tripeptide tyroservatide (YSV) on gene-expression in human hepatocarcinoma BEL-7402 tumors transplanted to nude mice. Mol Carcinog 45:197–203. doi:10.​1002/​mc.​20172 CrossRefPubMed
go back to reference Li A, Dubey S, Varney ML, Dave BJ, Singh RK (2003) IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170:3369–3376PubMed Li A, Dubey S, Varney ML, Dave BJ, Singh RK (2003) IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170:3369–3376PubMed
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108CrossRefPubMed Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108CrossRefPubMed
go back to reference Poon RT, Ng IO, Lau C, Zhu LX, Yu WC, Lo CM, Fan ST, Wong J (2001b) Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann Surg 233(2):227–235CrossRefPubMed Poon RT, Ng IO, Lau C, Zhu LX, Yu WC, Lo CM, Fan ST, Wong J (2001b) Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann Surg 233(2):227–235CrossRefPubMed
go back to reference Poon RT, Ng IO, Lau C, Yu WC, Yang ZF, Fan ST, Wong J (2002) Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study. J Clin Oncol 20:1775–1785CrossRefPubMed Poon RT, Ng IO, Lau C, Yu WC, Yang ZF, Fan ST, Wong J (2002) Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study. J Clin Oncol 20:1775–1785CrossRefPubMed
go back to reference Ren Y, Poon RT, Tsui HT, Chen WH, Li Z, Lau C, Yu WC, Fan ST (2003) Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis. Clin Cancer Res 9:5996–6001PubMed Ren Y, Poon RT, Tsui HT, Chen WH, Li Z, Lau C, Yu WC, Fan ST (2003) Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis. Clin Cancer Res 9:5996–6001PubMed
go back to reference Rolfe MW, Kunkel SL, Standiford TJ, Chensue SW, Allen RM, Evanoff HL, Phan SH, Strieter RM (1991) Pulmonary fibroblast expression of interleukin-8: a model for alveolar macrophage derived cytokine networking. Am J Respir Cell Mol Biol 5(5):493–501PubMed Rolfe MW, Kunkel SL, Standiford TJ, Chensue SW, Allen RM, Evanoff HL, Phan SH, Strieter RM (1991) Pulmonary fibroblast expression of interleukin-8: a model for alveolar macrophage derived cytokine networking. Am J Respir Cell Mol Biol 5(5):493–501PubMed
go back to reference Tang ZY (2002) Hepatocellular carcinoma: current status and prospects. Hepatobiliary Pancreat Dis Int 1:349–353PubMed Tang ZY (2002) Hepatocellular carcinoma: current status and prospects. Hepatobiliary Pancreat Dis Int 1:349–353PubMed
go back to reference Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumour angiogenesis and metastasis: correlation in invasive breast cancer. N Engl J Med 324:1–8PubMed Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumour angiogenesis and metastasis: correlation in invasive breast cancer. N Engl J Med 324:1–8PubMed
go back to reference Zhang ZL, Liu ZS, Sun Q (2006) Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma. World J Gastroenterol 12(26):4241–4245PubMed Zhang ZL, Liu ZS, Sun Q (2006) Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma. World J Gastroenterol 12(26):4241–4245PubMed
go back to reference Zhu ZT, Jia J, Lu R, Lu Y, Fu Z, Zhao L, Wang L, Jin M, Zhao L, Gao W, Yao Z (2006) Expression of PTEN, p27, p21 and AKT mRNA and protein in human BEL-7402 hepatocarcinoma cells in transplanted tumors of nude mice treated with the tripeptide tyroservatide (YSV). Int J Cancer 118:1539–1544CrossRefPubMed Zhu ZT, Jia J, Lu R, Lu Y, Fu Z, Zhao L, Wang L, Jin M, Zhao L, Gao W, Yao Z (2006) Expression of PTEN, p27, p21 and AKT mRNA and protein in human BEL-7402 hepatocarcinoma cells in transplanted tumors of nude mice treated with the tripeptide tyroservatide (YSV). Int J Cancer 118:1539–1544CrossRefPubMed
Metadata
Title
The antiangiogenic effects of tyroservatide on animal models of hepatocellular carcinoma
Authors
Ning Zhang
Lu Wang
Ying Liang
Yi-Ming Zhao
Qiong Xue
Wei-Zhong Wu
Hui-Chuan Sun
Jia Fan
Zhao-You Tang
Publication date
01-10-2009
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 10/2009
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-009-0589-1

Other articles of this Issue 10/2009

Journal of Cancer Research and Clinical Oncology 10/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.